I was scrolling through TikTok a couple of weeks back, when I suddenly came across a video that had me instantly intrigued.

Researchers from Drexel University’s College of Arts and Sciences and College of Medicine have found a potential new ...

In studies conducted by Eurofins Discovery, Telomir-1 was shown to potently inhibit UTX (KDM6A), an enzyme that acts like an ...

Synthetic Enzyme Therapy By David Kohn June 26, 2002 / 4:37 PM EDT / CBS MPS-1 occurs because the body is missing an enzyme that breaks down carbohydrates.

Approval of the enzyme replacement therapy is based on the results of two clinical trials, one in children and the other in adults.

Diseases like Pompe are treated by giving patients the enzyme they can’t make (hence the name enzyme replacement therapy), sometimes in combination with other medicines.

The enzyme replacement therapy started in late 2000, when researchers from BioMarin, a Novato-based pharmaceutical company, approached Dr. Paul Harmatz at Oakland Children's Hospital about setting ...

An enzyme therapy developed by Duke University researchers has been shown to improve heart and muscular functions -- and therefore prolong and enhance quality of life -- in infants born with Pompe ...

Enzyme replacement therapy (ERT) ERT replaces an enzyme that your body can’t make enough of, or can’t make at all, when you have Pompe disease.

Immunomodulation and Enzyme Therapy for Improved Efficacy Concomitant administration of an immunosuppressive agent with pegloticase can improve the response rate in patients with uncontrolled gout.